Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Alizamin Sadigov (Baku, Azerbaijan), Alizaman Sadigov, Sakhavatdin Akhundov, Jeyhun Ismailzadeh, Gunel Sadigova. FEV1 decline in patients with chronic obstructive pulmonary disease: Which treatment option is better for slowing of decline?. Eur Respir J 2015; 46: Suppl. 59, 660

Member's Comments

No comment yet.

Related content which might interest you: Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis Source: International Congress 2016 – COPD diagnosis and management Year: 2016 The decrease of nutritional status and increasing of the risk of osteoporotic fractures in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Clinical profile and treatment of elderly patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease. A comparative syudy Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD: points to ponder Year: 2014 To study the severity of lung hyperinflation and bone mineral density in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease Source: International Congress 2016 – Smoking-related diseases Year: 2016 The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 Early phenotypes of chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Different data in COPD Year: 2015 Symptom profile of exacerbations in earlier and later COPD Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 QVA149 reduces COPD exacerbation rate in various subgroups of patients: The SPARK study Source: Annual Congress 2013 –New bronchodilators for COPD management Year: 2013 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 Importance of the initial behaviour of patients in avoiding late recovery from COPD exacerbations Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Hyaluronic acid as a novel systemic biomarker to predict progression and severity in chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016